Caduceus Participates in “The Future of Health Industry: Precision Medicine Innovation Forum & Business Matchmaking” to Foster Global Collaboration Opportunities

Chairman Rung-Ywan Tsai (third from the left in the second row)

[Hsinchu, Taiwan] – On July 22, 2025 (Tuesday), Caduceus Biotechnology Inc. was invited to participate in “The Future of Health Industry: Precision Medicine Innovation Forum & Business Matchmaking”, guided by the Hsinchu Science Park Bureau, National Science and Technology Council (NSTC) and organized by the Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute (ITRI). The forum, held at the International Conference Hall, Hsinchu Biomedical Science Park R&D Center, brought together experts, scholars, innovative enterprises, and venture capital firms from around the world to discuss the latest developments and business opportunities in precision medicine.

During the event, Caduceus Biotechnology Inc. showcased its latest achievements and clinical applications of [Digital Biomarker Blood Test for Alzheimer's Disease (AD)], attracting significant attention from participants. The company engaged in in-depth exchanges with domestic and international industry partners, exploring potential collaborations in clinical applications, cross-border partnerships, and market expansion.

Rung-Ywan Tsai, Chairman of Caduceus Biotechnology Inc., stated: “Precision medicine is rapidly reshaping the global healthcare landscape. Caduceus will continue to invest in R&D and innovation, actively seek collaborations with international partners, and enhance Taiwan’s influence in the global precision medicine arena.”

The forum served not only as a platform for technological and trend exchange but also as a vital bridge to connect with international markets. Moving forward, Caduceus Biotechnology Inc. will remain committed to its core values of innovation, quality, and collaboration, working alongside global partners to drive the health industry to new heights.